Thursday, December 18, 2025 8:21:20 PM
The system allows that, and they milk as much as they can.
Potential shareholders need to be prudent. Trading, not investing, imo.
Recent SANA News
- Sana Biotechnology Announces Continued Positive Clinical Results Through 14 Months from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression • GlobeNewswire Inc. • 03/13/2026 01:00:00 PM
- Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers • Edgar (US Regulatory) • 03/03/2026 10:20:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/03/2026 09:11:19 PM
- Sana Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates • GlobeNewswire Inc. • 03/03/2026 09:05:00 PM
- Sana Biotechnology to Present at March 2026 Investor Conferences • GlobeNewswire Inc. • 02/23/2026 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/17/2026 02:07:30 PM
- Sana Biotechnology Appoints Brian Piper as Executive Vice President, Chief Financial Officer • GlobeNewswire Inc. • 02/17/2026 02:00:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 01/21/2026 05:30:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/14/2026 05:45:29 PM
- Sana Biotechnology to Present at the 44th Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/07/2026 09:26:32 PM
- Sana Biotechnology Announces Publication in Nature Biotechnology of in vivo Gene Editing of Human Hematopoietic Stem Cells in Preclinical Models Using the Fusogen Platform • GlobeNewswire Inc. • 12/08/2025 02:00:00 PM
- Sana Biotechnology to Present at December 2025 Investor Conferences • GlobeNewswire Inc. • 11/24/2025 09:05:00 PM
- Sana Biotechnology Reports Third Quarter 2025 Financial Results and Business Updates • GlobeNewswire Inc. • 11/06/2025 09:05:00 PM
- Sana Biotechnology to Present at the TD Cowen Immunology & Inflammation Summit • GlobeNewswire Inc. • 11/04/2025 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/05/2025 10:00:36 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/29/2025 08:11:52 PM
- Sana Biotechnology to Present at September 2025 Investor Conferences • GlobeNewswire Inc. • 08/26/2025 08:05:00 PM
- Biotech’s Big Bang: IPOs, Uplists, and the Short Squeeze Effect • AllPennyStocks.com • 08/21/2025 12:26:00 PM
- Sana Biotechnology Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares • GlobeNewswire Inc. • 08/20/2025 08:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2025 08:10:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/11/2025 08:08:34 PM
- Sana Biotechnology Reports Second Quarter 2025 Financial Results and Business Updates • GlobeNewswire Inc. • 08/11/2025 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2025 09:11:01 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/07/2025 08:37:49 PM
- Sana Biotechnology Announces Pricing of Public Offering • GlobeNewswire Inc. • 08/07/2025 03:24:08 AM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
RENI Completes Due Diligence on Target Acquisition; Confirms Strong Asset Base and Operational Performance • RENI • Mar 5, 2026 10:15 AM
BlackStar Engages in Talks with U.S. Senate Banking Committee Team Covering the Digital Asset Market Clarity Act • BEGI • Mar 4, 2026 4:47 PM
